NCT02252497View on ClinicalTrials.gov

Tranexamic Acid in Total Hip Arthroplasty.

PHASE4CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Hip Arthroplasty
Interventions
DRUG

Active comparator : Tranexamic Acid (Exacyl)

"* 1g Exacyl Intra Venous, just before surgery~* Then infusion of 1g of Exacyl over eight hours ."

DRUG

Placebo comparator : physiologic serum

"* 1g Intra Venous just before surgery~* Then infusion of 1g of physiologic serum over eight hours"

Trial Locations (1)

42055

CHU de Saint-Etienne, Saint-Etienne

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT02252497 - Tranexamic Acid in Total Hip Arthroplasty. | Biotech Hunter | Biotech Hunter